Breast reconstruction in low resource settings: Autologous latissimus dorsi flap provides a viable option.
Loading...
Date
2015-07
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
BACKGROUND: Breast reconstruction (BR) plays a significant role in the woman’s physical, emotional and psychological recovery from breast
cancer. However, the current most accepted methods of reconstruction are expensive, may require microsurgical skills and can be offered to a
very small number of patients seeking treatment in tertiary care centers. For the large majority of women seeking treatment in public hospitals,
solution lies in finding a method of reconstruction, which is autologous, produces a reasonable match to the contralateral breast in size, shape
and symmetry and produces minimal donor site morbidity. It should also be a technique, which is cost effective and can withstand the effects of
radiotherapy (RT). The autologous latissimus dorsi (LD) flap is one such versatile technique, which can serve as an ideal reconstructive option for the
majority of patients. MATERIALS AND METHODS: During a period of 6 years, 19 patients underwent immediate BR using this flap in the Department
of General Surgery. Patients who were young (mean age 37.4 years), had small to medium sized breasts, with operable breast cancer (Stage II
and IIIa) were selected for the procedure. RESULTS: Satisfactory cosmetic results as rated by patients as well as surgeons were achieved in the
majority. Donor site morbidities were seroma formation (78%) and donor site wound breakdown (21%). Post‑operative RT was well‑tolerated by
the reconstructed breast. CONCLUSION: Autologous LD flap reconstruction is a safe and economical option for BR in low resource settings and is
suitable for women with small and medium sized breasts.
Description
Keywords
Autologous latissimus dorsi flap, immediate breast reconstruction, seroma
Citation
Kaur N, Gupta A, Saini S. Breast reconstruction in low resource settings: Autologous latissimus dorsi flap provides a viable option. Indian Journal of Cancer. 2015 July-Sept; 52(3): 291-295.